) AR226-1382 # AR&R6 -- 1382 - v OUTLINE OF C-8 BLOOD SAMPLING PROGRAM employees'Thbelosoadmphlaisngspevreorgarlamputropodseetse.rminTehesleevealrse olfisCt-e8d bienlow oifn iorndteerntofofprpiroorgirtaym. wouIltdihsavfeelat ntehgaattiavneoivmepraacltl actommtuhinsicattimieo.n !

AR226-1392 | | | .

Po .

: cpp or 7 C05r1a1t6e7s20v0e0r11:11 AM RECEIVED OPP HCIC W0SEP-6 PH 12: 57 ARQ26 -- 0629 To: `KLBoaavrmbeaorrnlaDDLCCe/cIUzUSySEnPEsAPkIiAU/USDS@CE@/PUESAPE,APWAa/rUdS@PEePnAb,erMtahryy/DDoCmIiUnSiEaPAkI/UDSC@/EUPSAE,PAK/aUrSe@nEPA, Frank Sutiect Phaseout of FOS He i e Foardby ChasAUHDGAUSoEnOPS1A62U00S0 117 AM rerrrerrrmrcs |; IT # C1o6a1r2es00A0uer11:06 AM To: CM5.hasCrhleeEshuAAnuge@rF/mDeACg/oXUrS,E.PtAh3e/rUe0Ss@aE0gPiAg1,alb4oinne@5ttcie@Eci+ssu2C.0niKt,oH,JnsoaAthadnneDtBkiunecIgc.inasIixs@+e,CSc.EgkHBc.AcZRaa3,+fISroErISe01@T8en6dI6t29oD6g8,I45EV" 20 @ocd.or `TgaeMmCosrtEg@AebnFasduAaoanX@ss.hfu3tet0lae0mdea1,x+bjnSoo,EmRIhaaiCnnseOernN@rjOrtcM.KOto,cUhh+aRsE2aI3@@GAeb2nrav3y.2+ecSr0zE-,Mamgaadirok.ahT+yhma3al0nL1@5ae6EaK4-.6nGg5aao1nv3cs.3yae0u@,5i3o,h gobo. aIaruit@enkceermmussos.emta@leknau@rbownanreemeinmtpoodu.

:.

Attachment | Co Pagel AR226-1775 rath AIR DATA DUPONT WASHINGTON WORKS SITE "efTfhoirstss,ubbmoitthtaolfswuhmimcahriarzeesasasvoaciilaatbeldewiintfhorPmFatOiAonifnraoimr atthethfeoDlluoPwoinntg tWwaoshdiantgatcoonllWecotrikons site: 1.

BACK TO MAIN Study Title - Characterization Study of PFOS, Primary Standard Test Control Reference #TCR-000 17-046 PHASE: SOLUBILITY OF P F o S IN NATURALSEAWATER AND AN AQUEOUS SOLUTIO'NOF 3.5% SODIUMCHLORIDE Data Requirement 40 CFR 160.105(b) Author Mark E.

NorthwesBtioanalytical RSetpuodrytNNoo..NNWW''BBRS9998-=000852 ' Quantitative Determination of PFOS, PFOSA, PFOSA.A, N-MeFOSE-OH, N-EtFOSE-OH, POAA and PFHS in Human Serum by LC/MS/MS !

Co3rMpMooradtie TDeieeplaorgmyent &3MCroinve,sBsueitni220o-28.02 IM cma Janu27a, 2r00y3 eer iid al 1 DocumentProcessing Center EOfPfiAceEoasftPo-lRloutoimon6P4r28eAtvtu:eSanencttdiTioonxoi(cns) U12S0E0PPeAansylvaiaAveaveNW ~ WashiDCn2g046t0-o00n01 RE: TPSCeAr(E)fSlSuuU lfoonaP tre(PoP ROSoSU)L BCcMAIStSE #S2Ia7O9M Nn5:-D3eoE 9c3ketN No.T SEHQA -998-L374 `Dear DocketCoordinators: `3geMnehraatspiornervioeusplyrinfoordmeudtchetEPiAv(sSeteupldtyeidmnbeeartv1s4c,eo1n9ld9u8co)toepfdtwhmietreehspnuoltttassosafiulammult p`geernfclruaotrioooncptuapnsesualtfhoentawteo(hPiFgOhSe)sitdnowsheliecvheplesr(i1n.a6taalnmdo3rt.a2lmigt/yokcgc/udrarye)d.iIntMh.e Fy tshuabtsmeqoureeaptrleyciinsfeolrymdeefditnheedEthPeAN(Moar-ch2O8b,20s01e)orfLtvheevreeels(dul0t.

Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 1 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Appendix G: Amendments and Deviations (Copies) Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 2 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 3 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 4 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 5 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 6 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 7 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 8 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 9 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 10 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 11 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________ Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] Page 12 of 12 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats _____________________________________________________________________________________________________________

AR226-2090 61 6 a 5"~ 61^ S ;- * 0 3 0 5 A: 00 a> 0 M 5 ^. 1 tO 01 CT oi i a [ 01 m !

AR226-2206 Fine Powder C-8 Scrubber Particle Size Analysis ;<'";(,. ^

AR226-2429 ^f^ ^ CONCEPTUAL CLOSURE PLAN gtf/MPDES PERMIT APPLICAT - I O ^ N ^.

AR226-2769 FOR DO POHT USE ONLY CopieB to; POLYMER PRODdcTS OEPT.

AR226-2780 FOR DD FONT USE ONLY Copies Co: Haskell E.